HighVista Strategies’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

HighVista Strategies’s Portfolio RARX Stock Details RARX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-63,222	Closed	-$3.04M	–	121
2020 Q1	$3.04M	Buy	+63,222	New	+$2.94M	2.81%	10

Other funds holding RARX

Daiwa Securities Group Tokyo, Japan $51.1B AUM 35.55% 1-Year Est. Return

HighVista Strategies's RARX Position: Q2 2020 in Review

HighVista Strategies sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q2 2020, closing a stake of 63,222 shares — an estimated $3.04M sold.

HighVista Strategies first reported a position in RARX in Q1 2020 and held it in 1 quarter. The position peaked at $3.04M in Q1 2020. 1 fund tracked by Wall St. Rank holds RARX as of Q2 2020.

HighVista Strategies reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
HighVista Strategies sold 63,222 Ra Pharmaceuticals, Inc. Common Stock shares in Q2 2020, an estimated $3.04M.
HighVista Strategies first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q1 2020 and held it in 1 quarter.
HighVista Strategies's Ra Pharmaceuticals, Inc. Common Stock position peaked at $3.04M in Q1 2020.
1 fund tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q2 2020.

Based on HighVista Strategies's 13F filing for Q2 2020, filed 14 Aug 2020.